+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05159687

Randomized, Placebo-Controlled Study of Atomoxetine to Prevent Vasovagal Syncope in Adults

Led by University of Calgary · Updated on 2024-05-09

180

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Vasovagal syncope VVS affects up to half of people and causes repeated fainting episodes that significantly reduce quality of life. Although some treatments exist, many patients cannot use them due to conditions like hypertension or heart failure. Researchers are studying atomoxetine, a medication approved for attention deficit disorder that acts as a norepinephrine transport inhibitor, to see if it can prevent syncope in adults with recurrent VVS. This trial aims to test atomoxetines ability to reduce fainting episodes and improve quality of life in these patients. The trial is a randomized, double-blind, placebo-controlled, crossover study where participants will receive atomoxetine 40 mg twice daily or a matching placebo. Each treatment period lasts six months, separated by a one-week washout. Dosing starts at 40 mg once daily for 3 to 7 days before increasing to twice daily. Researchers will compare the frequency of syncope episodes between the atomoxetine and placebo periods and assess effects on anxiety, quality of life, injury, and cost-effectiveness. Participants will be monitored over a 12-month period with assessments every 3 to 6 months. These include questionnaires measuring anxiety, depression, quality of life, and medical utilization. Saliva samples will be collected to study genetic factors influencing treatment response. The primary outcome is the proportion of patients experiencing at least one syncope recurrence during each treatment phase. The study also includes safety monitoring and evaluates the broader impact of atomoxetine on patients well-being.

CONDITIONS

Brief Title

Study of Atomoxetine in the Prevention of Vasovagal Syncope

Research Team

R

Robert Sheldon

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here